Aryl Hydrocarbon Receptor Modulation by Tuberculosis Drugs Impairs Host Defense and Treatment Outcomes
Puyskens A., Stinn A., van der Vaart M., Kreuchwig A., Protze J., Pei G., Klemm M., Guhlich-Bornhof U., Hurwitz R., Krishnamoorthy G., Schaaf M., Krause G., Meijer AH., Kaufmann SHE., Moura-Alves P.